Infrapatellar Nerve Block for Post-operative Knee Arthroscopy Pain Control
Phase 4
Completed
- Conditions
- Internal Derangement of Knee
- Interventions
- Drug: Normal SalineDrug: 0.25% Bupivacaine
- Registration Number
- NCT01279447
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy.
- Detailed Description
The purpose of this study is to determine whether infrapatellar branch of the saphenous nerve blocks are effective in decreasing analgesic use, promoting earlier mobility, and improving long term outcome scores after knee arthroscopy. Randomized, double-blinded, placebo controlled, study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
- planned knee arthroscopy with soft tissue intervention
- age 18+
- English speaking
Read More
Exclusion Criteria
- contraindications to nerve block: eg neuropathy, type 1 diabetes, coagulopathy
- knee arthroscopy with planned bony intervention
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Normal Saline A sham infrapatellar block performed under US guidance with normal saline Infrapatellar nerve block 0.25% Bupivacaine An infrapatellar nerve block performed under US guidance with 0.25% bupivacaine
- Primary Outcome Measures
Name Time Method Post op Pain Score 0 hours immediate postop pain score, Visual Analog Scale. Evaluates pain on scale from 0-10. 0=no pain. 10=maximum pain.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Olson Surgical Pavilion
🇺🇸Chicago, Illinois, United States